Amedeo's Top 20

Amedeo Smart

Independent Medical Education

16 September 2019

Multidisciplinary Journal Club

  1. Yasuda S, Kaikita K, Akao M, Ako J, et al.
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med 2019.

  1. Tong TYN, Appleby PN, Bradbury KE, Perez-Cornago A, et al.
    Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPIC-Oxford study.
    BMJ 2019;366:l4897.

  2. Krysko KM, Henry RG, Cree BAC, Lin J, et al.
    Telomere length is associated with disability progression in multiple sclerosis.
    Ann Neurol 2019.

  3. Barkhof F, Kappos L, Wolinsky JS, Li DKB, et al.
    Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.
    Neurology 2019.

  4. Solomon SD, McMurray JJV, Anand IS, Ge J, et al.
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med 2019.

  1. Thuijs DJFM, Kappetein AP, Serruys PW, Mohr FW, et al.
    Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
    Lancet 2019.

  2. .
    Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet 2019.

  3. Abbink P, Mercado NB, Nkolola JP, Peterson RL, et al.
    Lack of therapeutic efficacy of an antibody to alpha4beta7 in SIVmac251-infected rhesus macaques.
    Science 2019;365:1029-1033.

  4. Owens DK, Davidson KW, Krist AH, Barry MJ, et al.
    Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA 2019;322:857-867.

  5. Sandborn WJ, Ferrante M, Bhandari BR, Berliba E, et al.
    Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
    Gastroenterology 2019.

  1. Baron TH, DiMaio CJ, Wang AY, Morgan KA, et al.
    American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis.
    Gastroenterology 2019.

  2. Marsh K, Eaton JW, Mahy M, Sabin K, et al.
    Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target.
    AIDS 2019.

  3. Yusuf S, Joseph P, Rangarajan S, Islam S, et al.
    Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
    Lancet 2019.

  4. Darricarrere N, Pougatcheva S, Duan X, Rudicell RS, et al.
    Development of a Pan-H1 Influenza Vaccine.
    J Virol 2018.

  5. Guo Y, Wang H, Zhang H, Liu T, et al.
    Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study.
    J Am Coll Cardiol 2019.

  1. Courlet P, Stader F, Guidi M, Saldanha SA, et al.
    Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging patients enrolled in the Swiss HIV Cohort Study.
    AIDS 2019.

  2. Visvanathan K, Fabian CJ, Bantug E, Brewster AM, et al.
    Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update.
    J Clin Oncol 2019.

  3. Schefold JC, Krag M, Marker S, Perner A, et al.
    Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial.
    Am J Nephrol 2019.

  4. Berman J.
    Liposomal Amphotericin B Treatment and the Leishmaniases.
    Am J Trop Med Hyg 2019.

  5. Castro FOF, Silva JM, Dorneles GP, Barros JBS, et al.
    Distinct inflammatory profiles in HIV-infected individuals under antiretroviral therapy using cannabis, cocaine or cannabis plus cocaine.
    AIDS 2019;33:1831-1842.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016